Document is current
Any future updates will be listed below
-
Authors
Xu, Man
Liu, Hao
Dai, Anran
Tan, Qilian
Zhang, Xinlong
Ding, Rui
Chen, Chen
Zou, Jianjun
Li, Yongjun
Si, Yanna
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82173899, 81873954)
Jiangsu Pharmaceutical Association (H202108)
Natural Science Research of Jiangsu Higher Education Institutions of China (BK20241730)
Six Talent Peaks Project in Jiangsu Province (WSW-106)
Nanjing Medical Science and Technical Development Foundation (ZKX22030)
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 2 July 2025
First Online: 5 August 2025
Declarations
:
: The institutional review boards (IRBs) of Nanjing First Hospital (Nanjing, Jiangsu, China) approved this study on the basis of the Helsinki declaration (Protocol code: KY20220621-04-KS-01) and waived the written informed consent requirement owing to the retrospective nature of this study.
: Not applicable.
: The authors declare no competing interests.
